HRT – it’s good for the heart

29th November 2012 by Louise Hudman

This article from the BMJ on the effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women was bought to my attention by a member who felt that its message was important for all of us to see, given recent safety concerns about HRT use.

1006 healthy, white women were selected. They were either recently (within 2 yrs) postmenopausal, or were peri-menopausal. They were aged 45 to 58. They were randomly allocated to either receiving HRT (cases), or not (controls). HRT used was triphasic, or oestradiol alone if they had no uterus. The composite ‘primary endpoint’ was death, admission to hospital for heart failure and MI. The study was stopped after 10 yrs because of safety concerns from other studies.

After 10 years, significantly fewer cases experienced the ‘primary endpoint’ than controls (hazard ratio 0.48, 3% cases vs 6.5% controls). This was not associated with a significant increase in any cancer, breast cancer, DVT nor stroke. At 16 years, there was still a reduction in the primary composite endpoint.


Join to view the rest of this content, as well as access all the benefits of joining NASGP.



Already a member? Login to view this content.


"The quality and contents of the magazine are superb. It's wonderful that GP locums now have a voice and are seen as a vital part of the medical workforce."

Dr Irene Bainbridge

See the full list of features within our NASGP membership plans